(R)-V-0219 hydrochloride

• CAT Number: I041376
• Molecular Formula: C20H26ClF3N4O2
• Molecular Weight: 446.89
• Purity: ≥95%
• Synonyms: 4-[[(3R)-1-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperidin-3-yl]methyl]morpholine;hydrochloride
• InChI: InChI=1S/C20H25F3N4O2.ClH/c21-20(22,23)17-5-3-16(4-6-17)19-24-18(29-25-19)14-27-7-1-2-15(13-27)12-26-8-10-28-11-9-26;/h3-6,15H,1-2,7-14H2;1H/t15-;/m1./s1
• InChIKey: PTRIYHLSBQMDQM-XFULWGLBSA-N
• SMILES: C1C[C@@H](CN(C1)CC2=NC(=NO2)C3=CC=C(C=C3)C(F)(F)F)CN4CCOCC4.Cl

(R)-V-0219 hydrochloride（Cat No.:I041376）is a chiral small molecule compound that acts as a selective inhibitor of certain protein targets involved in disease pathways, particularly in cancer and neurodegenerative diseases. The (R)-enantiomer of V-0219 has shown enhanced potency and specificity, making it a valuable tool in preclinical research for evaluating its therapeutic potential. By modulating critical signaling pathways, (R)-V-0219 hydrochloride has demonstrated promise in inhibiting tumor growth and neuroinflammation. Ongoing studies aim to further explore its pharmacological properties and potential clinical applications in targeted therapies for various conditions.